Weave Bio, an AI-native regulatory automation management provider based in San Francisco, raised $20M in a Series A round led by USVP with participation from Innovation Endeavors, Magnetic Ventures, Character, TMV and Serrado Capital. The funding will be used to accelerate product development and expand the company's offerings.
Comments
Want to join the conversation?
Loading comments...